Document Detail


Efficacy of 3% diclofenac gel for the treatment of actinic keratoses: a randomized, double-blind, placebo controlled study.
MedLine Citation:
PMID:  17050927     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Actinic keratoses (AKs) are premalignant skin lesions caused by excessive sun exposure. AIMS: To explore the therapeutic efficacy of 3% diclofenac in 2.5% hyaluronan gel in the topical treatment of AK. METHODS: Sixty-four lesions in 20 patients were evaluated. They were randomized to receive either the active treatment, 3% diclofenac in 2.5% hyaluronan gel or placebo, which consisted of the inactive gel vehicle, hyaluronan for a period of three months. The collected data were analyzed by using Student t- tests. RESULTS: There was a reduction in the lesion size in 64.7% of diclofenac-treated lesions and 34.3% of control lesions during the three-month course of treatment. Only 9.3% of the lesions in the diclofenac group were completely cleared during three months of treatment. During the treatment, no significant side-effect was observed in both groups. CONCLUSION: Considering the malignant potential of actinic keratoses and the importance of clearing them to prevent their transformation to squamous cell carcinoma, the efficacy of diclofenac gel seen in our study seems to be low. This treatment may be useful for patients who do not tolerate other, more effective kinds of treatment for actinic keratoses.
Authors:
Iraji Fariba; Asilian Ali; Siadat Amir Hossein; Safavai Atefeh; Seyed Afshin Atarzadeh Behbahan
Related Documents :
6993677 - Long-term treatment of symptomatic osteoarthritis with benoxaprofen. double-blind compa...
1365487 - Double-blind, randomized and parallel comparison between droxicam and diclofenac sodium...
22678407 - The efficiency of the acupressure in prevention of the chemotherapy-induced nausea and ...
20728707 - The effect of premedication with ibuprofen and indomethacin on the success of inferior ...
2606587 - Client demographics and outcome in outpatient cocaine treatment.
18435187 - Anticariogenic and antibacterial properties of a copper varnish using an in vitro micro...
Publication Detail:
Type:  Comparative Study; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Indian journal of dermatology, venereology and leprology     Volume:  72     ISSN:  0973-3922     ISO Abbreviation:  Indian J Dermatol Venereol Leprol     Publication Date:    2006 Sep-Oct
Date Detail:
Created Date:  2006-10-19     Completed Date:  2007-01-01     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7701852     Medline TA:  Indian J Dermatol Venereol Leprol     Country:  India    
Other Details:
Languages:  eng     Pagination:  346-9     Citation Subset:  IM    
Affiliation:
Department of Dermatology, Isfahan University of Medical Sciences, Isfahan, Iran. iraji@med.mui.ac.ir
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Topical
Adult
Aged
Diclofenac / administration & dosage*
Double-Blind Method
Female
Gels
Humans
Keratosis / drug therapy*,  pathology
Male
Middle Aged
Precancerous Conditions / drug therapy*,  pathology
Chemical
Reg. No./Substance:
0/Gels; 15307-86-5/Diclofenac

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Helicobacter pylori FlhB function: the FlhB C-terminal homologue HP1575 acts as a "spare part" to pe...
Next Document:  Indirect immunofluorescence to demonstrate lichen planus specific antigen (LPSA) in lichen planus.